Human papillomavirus (HPV) infection is the pathogenesis of anogenital cancers and genital warts in both men and women, whereas there is a scarcity of large studies focused on HPV prevalence in different anogenital sites of both sexes in the same population. From May to July 2014, 2,309 men and 2,378 women aged 18-55 were enrolled from communities in Liuzhou, China. Penis/glans penis/coronary sulcus (PGC) and perianal/anal canal (PA) specimens of men, and vaginal (VA), vulvar (VU) and PA specimens of women, were collected and genotyped for HPV. The prevalence of any HPV tested in PGC and PA samples from men and VA, VU and PA samples from women was 10.8%, 3.8%, 14.2%, 13.3% and 8.4%, respectively. The concordance of VA and VU was highest (kappa 5 0.74), followed by VU and PA (0.44), VA and PA (0.38) and PGC and PA (0.14). Besides sex behavior, ever having used a towel supplied by a hotel was a risk factor for both external genital and PA HPV infection. Our data indicated that women were more of a major reservoir for oncogenic HPV infection of both genital sites and PA sites than was men. In both sexes, the genital sites were more likely than PA sites to harbor HPV infection. The concordance rates of HPV infection between genital sites and PA infection were poor.
Introduction
Anogenital human papillomavirus (HPV) infection is very common in sexually active men and women throughout the world, although the distribution of the HPV burden may greatly differ in different countries. 1 HPV is mainly transmitted through sexual intercourse, and therefore, it is important to understand the distribution and concordance of HPV infection in different anogenital sites in both sexes, as this information will provide an epidemiological basis for developing the most cost-effective strategies to prevent and control HPV infection. Harald Zur Hausen reported that HPV infection could cause cervical cancer in 1970s, and this fact-coupled with the high burden of cervical cancer-led to the publication of various studies regarding the prevalence of cervical HPV infection, and their findings can help us to understand the global burden of cervical HPV infection in women. [2] [3] [4] [5] However, HPV is also associated with anogenital cancers other than cancer of the cervix, including vaginal, vulvar, penile and anal cancers in both sexes, 6 and this association has stimulated renewed interest in the burden of HPV infection in the corresponding sites in men and women. Thus, data regarding HPV infection of these anogenital sites in men and women have recently been published. However, most of these studies only focused on either men [7] [8] [9] or women, [10] [11] [12] [13] or these studies only focused on one anogenital site, [14] [15] [16] and therefore, direct comparison of HPV prevalence in different anogenital sites of men and women were hampered by differences in the population enrolled, the sampling methods and the HPV testing methods.
The aim of our study was to assess the prevalence and concordance of HPV infection in different anogenital sites of men and women who were enrolled from the same community. We used the same protocol to test HPV DNA in samples of the penis/glans penis/coronary sulcus (PGC) and perianal/anal canal (PA) of men, and the vagina (VA), vulva (VU) and PA of women. In addition, we analyzed the factors associated with HPV infection in different anogenital sites.
Material and Methods

Study site
Liuzhou City, locating in the center of Guangxi Zhuang Autonomous Region, South-West of China, is an area with high incidence of sexually transmitted diseases. It features a subtropical monsoon climate. There are 44 ethnic groups in Liuzhou, including Han, Zhuang, Dong, Miao and Yao and so on. Among these, the Han population accounts for 44.3% and followed by Zhuang (35.8%). Living together, the Zhuang nationality had been assimilated by the Han nationality, and now they have already similar living habits.
Sample size
This is a prospective cohort study which enrolled men and women from the general population. The primary objective of the cohort study was to clarify the incidence of anogenital warts in the general population. The incidence of anogenital warts was assumed to 1.5 per 1,000 person-years. 17 A sample size of 3,353 would produce a two-sided 95% confidence interval (CI) with a width equal to 0.003 when the sample proportion was 0.0015 (PASS, CIs for One Proportion). Assuming 20% of the subjects might loss to follow-up, the sample size should be 4,200. The second objective was to clarify the high-risk HPV prevalence of the general popula-
) was used to evaluate the sample size, and 3,600 subjects were needed based on the hypothesis that the high-risk HPV prevalence (p) 5 10%, 2, 18 d 5 0.1p and a 5 0.05. Assuming non-response rate was 20%, we would need to enroll 4,500 individuals. To achieve both objectives, 4,500 volunteers should be enrolled in the study. The ratio of the enrolled volunteers in the 4 age groups (18-25, 26-35, 36-45 and 46-55) should be 1:1:1:1 and the number of male and female volunteers in each age group should be similar.
Study population
Men and women who aged 18-55 years, ever had experienced sexual activity at enrollment, were willing to refrain from sexual activity (including vaginal and anal penetration, and any genital contact) and were willing to refrain from washing their genitals within 48 hr prior to sample collection were enrolled in Liuzhou. Individuals who had received the HPV vaccine, reported serious illnesses, were currently pregnant women, or had plans to relocate during the 1-year study were excluded from the study. From May to July 2014, a total of 2,191 men and 2,335 women were enrolled from the general population by advertisements, flyers, posters and educational presentations. As many young people left home for high education, it's difficult to enroll adults aged 18-25 years from the community, so another 118 men and 43 women were enrolled from college students by the same methods. Written informed consent was obtained from all study subjects. The study was approved by the Ethics Committee of the Liuzhou Center for Disease Control and Prevention (CDC).
Study procedures
This article presented the baseline data of the prospective cohort study. The details of the study procedures at the enrollment visit have been described previously. 19 In brief, participants were interviewed individually by a trained samesex interviewer in an independent room to complete a questionnaire that elicited information regarding general social demographic characteristics, personal hygiene habits and sexual behaviors. After the interview, a trained clinician completed the clinical examination and collected samples of different anogenital sites. For men, two saline-pre-wetted iCleanhcy TM flocked swabs (Huachenyang Corporation, Shenzhen, China) were used to collect PGC and PA specimens. For women, three iCleanhcy TM -flocked swabs were used to collect VA, VU and PA specimens. Each swab was placed into a separate vial containing 1 ml of PreservCytV R solution (Hologic Corporation, Marlborough, MA) and stored at ambient temperature. All of the samples were transported to the laboratory of Zeesan Biotech Corporation, Xiamen, China, within 2 weeks for detection and typing of HPV DNA.
HPV DNA testing
The swabs were tested for HPV DNA as described elsewhere. 19 Briefly, the DNA was extracted using the Lad-Aid
What's new?
Comparing the prevalence of human papilloma virus (HPV) infection in different anogenital sites is difficult because of inconsistencies in the methods used in different studies. Here, the authors systematically analyzed HPV retrieved from different sites in more than 4,000 men and women in communities in South-Western China with a high incidence of sexually transmitted diseases. In both sexes, genital sites were more likely to harbor HPV than was the perianal site, and the HPV type concordance was poor between genital and perianal sites. Interestingly, usage of hotel towels was a risk factor for external genital and perianal, but not vaginal HPV infection, underscoring the importance of personal hygiene and direct contact in acquiring the infection.
824 system (Zeesan Biotech Corporation, Xiamen, China). The polymerase chain reaction (PCR) consensus primer system (GP51/61) was used to amplify a fragment of the HPV L1 gene. Genotyping was conducted using a melting curve analysis for 16 types, including 13 oncogenic (HPV 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59 and 68) and 3 non-oncogenic HPV types (HPV 6, 11 and 66). 20 The accuracy and possible contamination were assessed using a negative control (H 2 O) and positive controls (containing HPV 16, 45 and 58 positive plasmids). 20 Also, glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used to determine the adequacy of the specimens.
Statistical analysis
A sample was considered to be adequate if the GAPDH was positive, or if the HPV genotyping was positive in the GAPDH-negative sample, which may be caused by DNA degradation. A specimen with at least one positive for any of the 16 tested HPV types was regarded as positive for any HPV. Specimens that showed at least one positive for 13 oncogenic types were regarded as positive for any oncogenic HPV.
The prevalence of the following categories of HPV infection was calculated for different anogenital sites of men and women: any HPV infection, any oncogenic HPV infection, The data are number (%). n is the number of specimens positive for either glyceraldehyde-3-phosphate dehydrogenase (GAPDH) or HPV DNA. 1 Positive for at least one HPV type (HPV 6, 11, 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66 or 68). 2 Using the Bonferroni test, the results from the PGC specimens from men were found to be significantly different from the VA and VU specimens from women with p < 0.0167 for each comparison. 3 Using the Pearson's v 2 test or Fisher exact test, the results from the PA were found to be significantly different from those from the PGC in men; p < 0.05. 4 Using the Pearson's v 2 test or Fisher exact test, the results from the PA specimens from men were found to be significantly different from those from the PA specimens from women; p < 0.05. 5 Using the Bonferroni test, the results from the PA specimens were found to be significantly different from the VU or VA specimens in women; p < 0.0167 for each comparison. 6 Positive for at least one oncogenic HPV type (HPV 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59 or 68). 7 Positive for at least one nine-valent vaccine-related HPV type (HPV 6, 11, 16, 18, 31, 33, 45, 52 or 58). 8 Positive for at least one quadrivalent vaccine-related HPV type (HPV 6, 11, 16 or 18). 9 Positive for at least one bivalent vaccine-related HPV type (HPV 16 or 18).
nine-valent vaccine-related HPV types (9v HPV) infection, quadrivalent vaccine-related types (4v HPV) infection, bivalent vaccine-related types (2v HPV) infection, HPV 6 or 11 infection and type-specific HPV infection. The prevalence of HPV at different sites was compared by using Pearson's v 2 test, Fisher exact test, or the Bonferroni test. The CochranArmitage test was used to assess age trends for grouped HPV infection of different anogenital sites.
The kappa values of any, oncogenic, and type-specific HPV infection in men (between PGC and PA) and women (between VA and VU, between VA and PA and between VU and PA) were calculated. The 
Odds ratios (ORs) and corresponding 95% CIs were calculated to estimate independent predictors by unconditional logistic regression for 5 outcomes: any HPV infection in PGC and PA sites of men, and in VU, VA and PA sites of women. Final models were determined by the stepwiseselection of candidate variables with a p-values <0.20 in the bivariate logistics analysis. The data were analyzed by using SAS version 9.4 (SAS Institute, Cary, NC).
Results
In total, 2,309 men and 2,378 women aged 18-55 years were enrolled and had anogenital specimens collected. After removing the samples that tested negative for both GAPDH and HPV DNA, 1,513 (65.5%) samples of PGC and 1,412 (61.2%) samples of PA among men and 2,340 (98.4%) samples of VA, 2,327 (97.9%) samples of VU and 2,283 (96.0%) samples of PA among women remained in the analysis. The distributions of most sociodemographic and sexual behavioral characteristics were similar among men and women who provided at least one adequate specimen. 19 In both sexes, genital sites were more likely to harbor HPV infection than was PA site. The prevalence of HPV infection in both genital sites and PA sites was higher in women than in men. Overall, the detection of HPV DNA of any type was most prevalent in samples from the VA (14.2%) and VU (13.3%) of women, followed by samples from the PGC of men (10.8%), PA specimens of women (8.4%) and the PA specimens of men (3.8%) ( Table 1 ). The same order was observed for other grouped HPV types (oncogenic, 9v, 4v and 2v HPV) excluding HPV 6 or 11 for which no statistical difference was found in the anogenital sites of both sexes.
Of the types tested, oncogenic HPV 58 (3.1% of PGC specimens and 1.5% of PA specimens) was the most common HPV type among men, followed by HPV 52 and 39 in the PGC specimens, whereas the presence of the other types in the PGC or PA specimens was uncommon, with an occurrence of <1.0%. For any site in women, the three most common types were HPV 52 (4.8% of VA, 4.4% of VU and 2.4% 
Any HPV This analysis is based on 988 men who had adequate penis/glans penis/coronary sulcus (PGC) and perianal/anal canal (PA) samples, and 2,279 women who had adequate vagina (VA), vulva (VU) and PA samples. 
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of PA specimens), HPV 58 (2.3%, 2.3% and 1.5%) and HPV 16 (2.1%, 2.1% and 1.4%). The concordances of HPV infection type between different sites for men and women were estimated (Table 2 ). In women, regardless of the type of HPV infection (any, oncogenic or type-specific), VA-based HPV detection was in great agreement beyond chance with that of VU specimens (kappa 0.70), whereas VA and PA specimens, and VU and PA specimens, had moderate agreement with HPV infection ( 0.45). However, in men, the kappa value was poor in specimens of PGC and PA (only 0.10).
The prevalence of oncogenic, 9v and 2v HPV types in different sites in women decreased with increasing age, whereas the rates in different sites in men remained stable in different age groups (Fig. 1) . However, the prevalence of HPV 6 or 11 in different sites was similar among different age groups in both men and women.
We estimated the risk factors for HPV detection at any anatomical site for men and women (Table 3) . In contrast to the relatively stable HPV prevalence of different age groups in PGC and PA specimens from men in the bivariate analysis, a higher rate in VA, VU and PA specimens was reported in women aged 18-25 years, although this difference was not significantly different after adjusting for other factors. In multivariate analyses, men who had ever used a towel supplied by a hotel (OR 5 1.8, 95% CI: 1.3-2.6) or reported their sexual partners ever having sex with others (OR 5 2.3, 95% CI: 1.2-4.5) were more likely to have external genital HPV infection. However, in the PA specimens of men, no factors were independently associated with HPV infection owing to a lower number of positive specimens to analyze. For women, compared to those from a rural area, women in urban settings had a significantly increased risk of HPV infection, with an OR of 1.5 (95% CI: 1.2-2.0) for VA, 1.9 (95% CI: 1.4-2.7) for VU and 2.0 (95% CI: 1.4-3.0) for PA specimens. Sexual behavior factors, such as the lifetime number of sexual partners and the number of sexual partners within the past year, were independently associated with any anogenital HPV infection in women. Notably, women who reported ever using a towel supplied by a hotel were more likely to have prevalent HPV DNA detected in samples from the VU (OR 5 1.3, 95% CI: 1.1-1.7) and PA (OR 5 1.7, 95% CI: 1.2-2.4), but not in samples from the VA.
Discussion
This is the first large study focused on the prevalence of HPV in different anogenital sites of both men and women in China. Our data indicated that the burden of carcinogenic HPV infection was higher in the anogenital sites of women than in those of men, even in the PA site, which is anatomically similar between the two sexes. The prevalence of HPV decreased in the different anogenital sites of women with increasing age, whereas this ORs and 95% CIs were derived by univariate logistic regression analysis; AORs and 95% CIs were derived by multivariate logistic regression models with stepwise selection. 1 The p of two varibles was lower than 0.20 in the bivariate analysis (ever having used a towel supplied by a hotel and sexual partners ever having sex with others) and remained in the multivariate regression model. 2 Income and number of sexual partners in past year remained in the multivariate regression model, but neither was statistically significance. 3 Age group, region, marital status, ever having used a sauna, ever having used a towel supplied by the sauna, ever stayed at a hotel, ever having used a towel supplied by a hotel, lifetime number of sexual partners, number of sexual partners within the past year, the frequency of condom use, sexual partners having sex with others and previous sexual transmitted diseases diagnosis remained in the multivariate regression model. 4 Variables include education and all the above variables entered in the multivariate regression model for VA site.
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trend was not observed for the different sites in men. The concordance between the genital site and the PA site was poor, especially in men. The risk factors for HPV infection were living in urban areas, ever using a towel supplied by a hotel, more lifetime sexual partners and more sexual partners within the past year. As Giuliano et al. mentioned, understanding site differences of HPV infection is essential to the development of efficacious interventions to prevent HPV-related cancers afflicting both men and women. 21 Unfortunately, there is a scarcity of studies included both men and women from the same general population, and even fewer studies included sampling at multiple anatomic sites. Our data raised some interesting questions: (1) HPV prevalence in vagina was similar as that in vulva (any oncogenic HPV: 13.4% vs. 12.8%), and the concordance of infected HPV types was high between the two sites (kappa 5 0.72 and 0.78 for HPV 16 and 18). However, the incidence of HPV-related cancer in vagina is higher than that in vulva worldwide. HPVattributable fraction in cancers of vagina and vulva are 24.9% and 78.0%, respectively. 22 The mechanism behind this phenomena remains to be further studied. (2) Although with the same anatomic structure, the prevalence of anal HPV infection was much higher in women than in men (HPV 16/18: 1.9% vs. 0.2%; 9v HPV: 6.5% vs. 2.8%), whereas, the reverse results were found in the number of anal cancer cases attributable to HPV in China in 2012 (3,600 female cases vs. 5,600 male cases). 22 About 87% and 95.9% of HPV-attributable anal cancer cases were caused by HPV 16/18 and the 9v types, respectively. (3) The prevalence of HPV was higher in genital sites than that in PA site in women (any oncogenic HPV: 13.4% and 12.8% vs. 8.0%), while the number of female anal cancer patients attributed to HPV infection was higher than female cancer patients of vulva and vagina caused by HPV infection in China (3,600 vs. 1,600). 22 So further studies focus on natural history of HPV infection in these sites in both sexes is important to explain the discrepancy between carcinogenic HPV infection and HPV-related cancers in different sites.
The rates of high-risk HPV infection in the different anatomic sites of women slowly decreased with increasing age, whereas in men, the rates were similar in different age groups. This observation is concordant with a previous study. 21 For low-risk HPV, no significant difference was observed for the prevalence among different age groups in both sexes. Again, the different age distribution models for high-risk and low-risk HPV deserve more prospective studies to unveil the natural history difference for high-risk and lowrisk HPV in women and men.
In our study, we observed a poor concordance between genital and anal sites in both sexes, which may be due to the differences in anatomical characteristics or clearance rates of HPV infection between the two sites, and it may also because the infected HPV originated from different infection sources.
However, the kappa value of the VA and VU sites was very high, which may suggest that viruses were coming from the same source, or were self-transmitted between the two sites, or the two sites had similar incidence or clearance rates. Our findings were similar to those of other studies of female anogenital sites, 10, 13 but in men, there were few studies regarding the concordance of type-specific HPV infection among the different sites, especially in China.
The data regarding the HPV type-specific distribution indicated that HPV 52 and HPV 58 were the most prevalent types in the different anatomic sites of females and in the genital sites of males, which is concordant with data reported in previous studies in China. 12, 23, 24 Although 14.0% of cervical cancer in China is caused by HPV 52 and HPV 58 infection, 33.3% of the high-grade cervical intraepithelial lesions are related to HPV 52 and HPV 58. 25 The data imply the importance of including HPV 52 and HPV 58 in the prophylactic HPV vaccine in China.
Similarly to previous studies, 9, 14, 18, 24, 26, 27 our study found that sexual factors-for example, the number of lifetime sexual partners and the number of sexual partners within the past year-have a strong influence on anogenital HPV prevalence in both sexes. Notably, we found that participants who had ever used a towel supplied by a hotel had a higher HPV prevalence at external genital and PA sites, whereas hotel towel usage was not associated with vaginal HPV detection. The possible reason may be that the external genital site is more easily influenced by the environment through direct contact. A study of uncircumcised Kenyan men 28 found that men with less frequent washing had a higher prevalence of HPV infection, which further indicates that external genital hygiene is associated with HPV infection.
A limitation to our study is the low proportion of GAPDH positivity in male anogenital sites, which might underestimate the burden of HPV infection in men. However, we believe that this possibility is quite low because there were no significant differences when we compared the data of men who had at least one adequate PGC or PA specimens and of men who had adequate PGC and PA specimens. In addition, information related to anal sex was not collected, which prevented us from analyzing the impact of anal sex on the burden of anal HPV infection.
In conclusion, genital sites more likely harbored HPV infection than the PA site in both sexes. The anogenital sites of women were more of a major reservoir for any HPV type than were those of men. Besides HPV vaccination, promoting anogenital hygiene may be worth considering to decrease the opportunity for HPV infection of anogenital sites in both sexes.
